FDG and Beyond

Recent Results Cancer Res. 2016:198:163-73. doi: 10.1007/978-3-662-49651-0_8.

Abstract

Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.

Keywords: FDG; Hypoxia; Molecular imaging; PET; Target volume; Tracer.

Publication types

  • Review

MeSH terms

  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Gallium Radioisotopes / pharmacokinetics
  • Humans
  • Magnetic Resonance Imaging / methods
  • Neoplasms / diagnostic imaging*
  • Neoplasms / metabolism*
  • Neoplasms / radiotherapy
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals / pharmacokinetics
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed / methods

Substances

  • Gallium Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18